Cardiff Oncology

CRDF

Börsenwert 70,1 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Laurion Capital Management New York	4,03 Mio. $	+716.943 $	+451.561	+17 %
2	2 Vanguard Capital Management Malvern, Pennsylvania	3,76 Mio. $	+62.914 $	+39.626	+1 %
3	P 3 Pfizer New York	3,01 Mio. $	–	–	–
4	4 Franklin Resources San Mateo, California	1,57 Mio. $	–	–	–
5	5 BlackRock New York	1,26 Mio. $	-4,78 Mio. $	-3.008.514	-76 %
6	6 William Blair & Company Chicago, Illinois	1,19 Mio. $	-15.709 $	-9.894	-1 %
7	7 Geode Capital Management Boston, Massachusetts	1,07 Mio. $	-1,24 Mio. $	-779.601	-49 %
8	8 UBS Group Zurich, Switzerland	830.309 $	+378.068 $	+238.123	+59 %
9	9 Jane Street New York	790.270 $	+901.488 $	+567.795	+1.416 %
10	10 Vanguard Fiduciary Trust Malvern, Pennsylvania	533.783 $	-56.559 $	-35.623	-8 %
11	11 AQR Capital Management Greenwich, Connecticut	450.260 $	+444.869 $	+280.197	+424 %
12	12 State Street Boston, Massachusetts	430.814 $	-1,36 Mio. $	-855.552	-72 %
13	13 HRT Financial New York	354.000 $	+433.102 $	+272.786	Neu
14	14 F.L. Putnam Investment Management Lynnfield, Massachusetts	321.716 $	-551.969 $	-347.653	-58 %
15	15 Morgan Stanley New York	319.924 $	+301.328 $	+189.789	+337 %
16	16 BNP Paribas Financial Markets Paris, France	296.999 $	+341.967 $	+215.385	+1.647 %
17	XSC 17 X-Square Capital Guaynabo, Puerto Rico	267.000 $	+326.590 $	+205.700	Neu
18	18 GSA Capital Partners London, United Kingdom	225.000 $	+79.807 $	+50.266	+41 %
19	19 Marshall Wace London, United Kingdom	210.879 $	+257.547 $	+162.214	Neu
20	20 Bank of New York Mellon New York	210.196 $	-225.039 $	-141.739	-47 %
21	21 Northern Trust Chicago, Illinois	198.738 $	-540.342 $	-340.330	-69 %
22	22 Avestar Capital New York	176.989 $	–	–	–
23	23 Millennium Management New York	174.872 $	+177.009 $	+111.488	+484 %
24	24 Qube Research & Technologies (QRT) London, United Kingdom	163.215 $	+199.336 $	+125.550	Neu
25	25 Goldman Sachs New York	157.076 $	-23.452 $	-14.771	-11 %

Cardiff Oncology CRDF Börsenwert 70,1 Mio. $

Cardiff Oncology

CRDF

Börsenwert 70,1 Mio. $